CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product (Q45387655)
Jump to navigation
Jump to search
scientific article published in December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product |
scientific article published in December 2008 |
Statements
1 reference
CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product (English)
1 reference
Venezuelan equine encephalitis virus
1 reference
Stuart D Perkins
1 reference
Amanda J Williams
1 reference
Lyn M O'Brien
1 reference
Thomas R Laws
1 reference
Robert J Phillpotts
1 reference
1 December 2008
1 reference
1 reference
Identifiers
1 reference